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Abstract 
 
Objective  
Cochrane systematic reviews require more methodological support from Cochrane Review Groups 
(CRGs) than is customary in journals, CRGs must prioritise reviews to conserve resources. The TRIP 
database provided a dataset of questions to guide prioritization for the Acute Respiratory Infections 
(ARI) CRG. 
 
Study Design and Setting  
We extracted the ARI searches from the TRIP database (2010 to 2017) that contained at least one 
disease and one clinical management term, (defined as a ‘search’), and tabulated these by frequency. 
 
Results 
There were 314,346 ARI searches from which we inferred 45,497 clinical questions, covering 365 
topics. In two thirds (30,541) these addressed only 20 clinical questions, of which treatment were 
the most frequent; followed by diagnosis, mortality and prognosis. The 5 most frequent clinical 
questions were “Influenza + Vaccination” 4,989 (12.1%), “acute otitis media + antibiotics” 3578 
(8.7%), “common cold + vitamin C” 3528 (8.6%), “meningitis + corticosteroids” 1,910 (4.6%), 
“pneumonia + general treatment” 1765 (4.3%). The 20 most frequent clinical questions were 
addressed by Cochrane reviews or protocols. 
 
Conclusion 
ARI questions are common and repeated often. Most may have been addressed by Cochrane 
reviews. The remainder form the basis of a priority list to assign resources for future Cochrane topics.   
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Database analysis 
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What is new 
 
Key findings 
• Analysing a clinical question-answering databank is a novel way to achieve Cochrane review 
prioritisation  
• Most clinical questions about acute respiratory infections addressed the same 20 topics, all 
treatment-type questions  
• The 20 most-common topics already were already addressed by Cochrane reviews or 
protocols  
 
What this adds to what is known 
• This research prioritisation method provides an alternative to the common methods (Delphi 
processes with stakeholders; audits of research undertaken and systematically reviewed). 
 
What is the implication, what should change now 
• These prioritisation findings need to be implemented to improve transparency of Cochrane 
editorial decisions.  
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Background 
Cochrane is a global organisation which produces high quality, credible, systematic reviews (SR) of 
the literature [1, 2], and provides methodological support at several stages, which is provided by one 
of several editorial teams. Since editorial support is expensive and limited, Cochrane needs to 
prioritise review topics [3-5]. Prioritisation projects usually solicit the views of patients, their 
clinicians, and other stakeholders [6-10]. 
The Cochrane Acute Respiratory Infections (ARI) Group, responsible for synthesising evidence 
syntheses about diseases causing ARIs, has also embarked on a priority list of topics [11]. Two 
projects have been completed: one identified gaps between current Cochrane reviews and research 
that has been undertaken [12]; a second was a survey of topics that stakeholders wanted answered 
[13]. 
This third project sought to identify topics that stakeholders had asked of the TRIP database 
(previously known as Turning Research Into Practice), an search engine designed to assist clinicians 
find evidence. There have been >100 million searches of the TRIP database [14]. The largest group of 
searchers are medical doctors (45%), then information-specialists (20%), other health professional 
(9%), nurses (8%), pharmacists (8%), and patients or their carers (1%) [14, 15]. However, there is 
some uncertainty about these proportions because the survey used to collect these data were 
derived from a sub-sample of users, (only those registered) [14]. 
Most searches (67%) aim to answer clinical questions (67%) [15, 16]. Critical components of clinical 
questions can be inferred from the search terms. Accordingly, we could analyse the TRIP database 
for searches limited to ARIs, to determine the topics most frequently searched, and then rank them. 
 
Aims 
To estimate the frequency of clinical questions asked about ARIs by users of the TRIP database for 
three question types (treatment, diagnosis, and prognosis). 
  
Methods 
We obtained data containing all searches conducted in the TRIP database between 2010 and 2017, 
and focussed on the keyword field, which contained the search terms used, (eg “xylitol otitis media”, 
“tuberculosis”, “transfer patient to the floor” and “eating disorder OR anorexia”, see Appendix 1, for 
more examples). Most searches in the TRIP database focused on the population, and few (12%) used 
Boolean operators [17]. To identify searches that were clinical questions, we selected only those 
with ≥2 different search terms, of which at least one was a disease, and at least one other a 
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treatment, diagnosis or prognosis. We tested this method on a convenient subsample of 1,543 
searches, finding 972 (63%) satisfied this, and could be classified as clinical questions. 
We now created two lists derived from search strategies used in Cochrane ARI Group reviews, and 
from our work on a previous prioritisation study [12]: 
1. ARI diseases and their synonyms 
2. treatments, diagnoses, and prognoses, and their synonyms.  
This enabled us to infer clinical questions being asked, (eg, when common cold and nasal irrigation 
occurred together, we inferred the clinical question, what is the efficacy of nasal irrigation for the 
common cold?), (Appendix Table 2 has a full list of search strings). 
By re-combining the words of the clinical questions into a string, we could interrogate TRIP to 
identify clinical questions, and then the number of diseases (and their synonyms) combined with 
treatments, diagnoses, or prognoses (and their synonyms). The data were entered onto a 
spreadsheet, with disease along one axis and treatments, diagnoses, or prognoses along the other, 
Table 1. The 20 most common ARI clinical questions are displayed, Figure 1. We checked for 
Cochrane reviews for these 20 most common clinical questions, Figure 1, (also Appendix Table 3). 
 
Results 
From 314,346 ARI searches conducted in TRIP, we could infer 45,497 questions. These addressed 
365 different topics, most addressing the same question, with the 20 most frequent addressing 
30,541 (two thirds, 67%) of the total. 
Treatment was the most frequent clinical question type: 41,191 (91%); diagnosis 2,299 (5%); 
mortality 1,172 (2.6%); and prognosis 834 (1.8%). Pneumonia was the illness asked about most, 
6,820 (15%); followed by influenza 6,495 (14%); the common cold 5,539 (12%) and acute otitis media 
5,154 (11%), Table 1. 
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Table 1: Total ARI clinical questions entered into TRIP 
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The most frequent full clinical questions were: influenza + vaccination 4,989 (12%); acute otitis 
media + antibiotics 3578 (9%); common cold + vitamin C 3,528 (9%); meningitis + corticosteroids 
1,910 (5%); and pneumonia + general treatment 1,765 (4%), Figure 1, (Appendix Table 4 lists all 
topics with ≥100 clinical questions) 
 
There was at least one associated Cochrane review for each of 18 of the 20 most frequent clinical 
questions: the two outstanding clinical questions, one (pneumonia + non-specific treatment) had 9 
completed Cochrane reviews (of specific treatments) that at least partly address it, and two 
Cochrane protocols that will answer it. The other (bronchiolitis + non-specific treatment) had 15 
completed Cochrane reviews (of specific treatments) partly addressing it, Figure 1. (Appendix Table 3 
lists top 20 topics with associated Cochrane reviews) 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
 
 
  
9
 2
1
-2
9
4
 3
0
-3
3
1
 3
4
4
 3
5
-3
8
0
*
 3
9
-4
9
4
 5
0
-5
3
1
2
 4
3
-4
7
,
5
4
-6
0
2
 6
1
,6
2
4
 6
3
-6
6
7
 6
7
-7
3
5
 7
4
-7
8
1
 7
8
8
 3
0
, 3
1
, 3
3
, 6
8
, 7
9
-8
2
1
 8
3
2
 8
4
, 8
5
6
 5
0
-5
3
, 6
2
, 8
6
1
 8
7
3
 4
0
, 8
8
, 8
9
, 9
0
1
 7
6
0
 *
8
4
, 8
5
, 9
1
-1
0
3
0
1000
2000
3000
4000
5000
6000
Figure 1: Top 20 ARI Clinical Questions with corresponding Cochrane Reviews (CR)#
* = protocols and/or other CRs partially answer the question; # = available in the on-line supplement (Appendix 5)
Number of
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Discussion 
We found a wide spectrum of clinical questions. Some were much more frequent. Treatment clinical questions were 
much more frequent than diagnosis or prognosis ones. The questions were already addressed by existing Cochrane 
reviews or protocols.  
Our study has some limitations. There is some uncertainty about who asks questions of the TRIP database. Our 
method of analysing the searches of the TRIP database made assumptions, particularly about what was being asked 
from the keywords, that may not have been valid.  
However, our approach has some strengths. The enormous size of the dataset means sampling errors are very 
unlikely. Rather than relying on volunteers to nominate topics (diseases and clinical managements) to prioritise in 
surveys, which may not represent what participants themselves, let alone what others want to know, our method, 
which analysed what people actually did ask, is clearly more direct.  
Our findings are largely concordant with other data on the most frequent type of clinical questions asked by doctors 
– mostly treatment (76%), although somewhat less than we found [18], perhaps because that study was of doctors 
only (we estimate 45% of TRIP users are doctors). Similarly, other studies of question-types asked have also found 
treatment questions of primary care physicians to be the most frequent [19, 20].  
 
This information can be used for transparently prioritising proposed Cochrane ARI reviews and their updates in a 
climate of competing resources. It can be used in conjunction with our previous prioritisation projects, (a list of 
systematic review research gaps [12], and opinions from representatives of ARI experts and consumers [13]). 
 
 
 
 
Funding 
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit 
sectors. 
Mr Clark reports grants from NHMRC (Australia),  during the conduct of the study; non-financial support from The 
Cochrane Collaboration, grants from ALIA Health Libraries Australia, outside the submitted work;  and salary part 
funded by a grant for the Cochrane ARI Group from NHMRC (Australia). 
Dr Carter has nothing to disclose. 
Dr Scott reports her salary funded by CREMARA grant (Centre for Research Excellence in Minimising Antimicrobial 
Resistance from Acute Respiratory Infections). 
Dr Brassey reports he is a shareholder (50%) in Trip Database Ltd and supplied the data used in this analysis. 
Dr Del Mar reports grants from NHMRC (Australia), during the conduct of the study; grants from NHMRC (Australia), 
grants from Australian ACSQHC, personal fees from Elsevier and Blackwells publishers,  outside the submitted work. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
References 
[1] The Cochrane Collaboration. Cochrane: about us. 2018. Accessed 14 May, 2018 Available at: 
http://www.cochrane.org/about-us 
[2] Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, et al. Systematic Differences between Cochrane 
and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. PLoS One. 2015;10:e0144980. 
10.1371/journal.pone.0144980: 10.1371/journal.pone.0144980 
[3] Bero LA, Binder L. The Cochrane Collaboration review prioritization projects show that a variety of approaches 
successfully identify high-priority topics. J Clin Epidemiol. 2013;66:472-3. 10.1016/j.jclinepi.2012.03.015: 
10.1016/j.jclinepi.2012.03.015 
[4] The Cochrane Collaboration. Cochrane Strategy to 2020. 2016.  Available at: http://community-
archive.cochrane.org/sites/default/files/uploads/Strategy%20to%202020_updated_Final_Feb2016.pdf 
[5] Nasser M, Welch V, Tugwell P, Ueffing E, Doyle J, Waters E. Ensuring relevance for Cochrane reviews: evaluating 
processes and methods for prioritizing topics for Cochrane reviews. J Clin Epidemiol. 2013;66:474-82. 
10.1016/j.jclinepi.2012.01.001: 10.1016/j.jclinepi.2012.01.001 
[6] Welsh E, Stovold E, Karner C, Cates C. Cochrane Airways Group reviews were prioritized for updating using a 
pragmatic approach. J Clin Epidemiol. 2015;68:341-6 
[7] Wale JL, Belizan M, Nadel J, Jeffrey C, Vij SL. The Cochrane Library review titles that are important to users of 
health care, a Cochrane Consumer Network project. Health Expect. 2013;16:e146-63. 10.1111/j.1369-
7625.2011.00723.x: 10.1111/j.1369-7625.2011.00723.x 
[8] Cochrane Tobacco Addiction Group. Cochrane Tobacco Addiction Priority setting workshop. 2016. Accessed 16 
November, 2016 Available at: http://tobacco.cochrane.org/priority-setting-workshop 
[9] Synnot A, Bragge P, Lowe D, Nunn JS, O'Sullivan M, Horvat L, et al. Research priorities in health communication 
and participation: international survey of consumers and other stakeholders. BMJ Open. 2018;8:e019481. 
10.1136/bmjopen-2017-019481: 10.1136/bmjopen-2017-019481 
[10] Synnot A. Stakeholder priorities for research in health communication and participation: findings from the 
Cochrane Consumers and communication prioity setting project. 2016.  Available at: 
http://www.latrobe.edu.au/__data/assets/pdf_file/0005/751361/CKA8075_LaTrobeUni.LTU.Cochrane_PriorityRepo
rt_FINAL_WEB.pdf 
[11] Cochrane Acute Respiratory Infections. Cochrane Acute Respiratory Infections About us. 2018. Accessed 08 May, 
2018 Available at: http://ari.cochrane.org/welcome 
[12] Alloo J, Vallath S, Del Mar C, Carter M, Thorning S, Clark J. Determining the gaps between Cochrane reviews and 
trials of effectiveness of interventions for acute respiratory infections: an audit. Systematic Reviews. 2017;6:82. 
10.1186/s13643-017-0472-0: 10.1186/s13643-017-0472-0 
[13] Scott A. Setting research priorities in systematic reviews: Cochrane Acute Respiratory Infections Group’s 
Stakeholder Engagement Project J Clin Epidemiol. 2018 
[14] Trip Database Ltd. Trip: about. 2017. Accessed 10 May, 2018 Available at: https://www.tripdatabase.com/about 
[15] Brassey J. Trip database blog: Survey ended, start of analysis. Trip; 2011. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
12 
 
[16] Stevens GA, Fitterling L, Kelly FV. Trip Database: Turning Research into Practice for Evidence-Based Care. Med 
Ref Serv Q. 2017;36:391-8. 10.1080/02763869.2017.1369288: 10.1080/02763869.2017.1369288 
[17] Meats E, Brassey J, Heneghan C, Glasziou P. Using the Turning Research Into Practice (TRIP) database: how do 
clinicians really search? J Med Libr Assoc. 2007;95:156-63. 10.3163/1536-5050.95.2.156: 10.3163/1536-
5050.95.2.156 
[18] Brassey J, Elwyn G, Price C, Kinnersley P. Just in time information for clinicians: a questionnaire evaluation of the 
ATTRACT project. BMJ. 2001;322:529-30 
[19] Ely JW, Osheroff JA, Gorman PN, Ebell MH, Chambliss ML, Pifer EA, et al. A taxonomy of generic clinical 
questions: classification study. BMJ. 2000;321:429-32 
[20] Ely JW, Osheroff JA, Maviglia SM, Rosenbaum ME. Patient-care questions that physicians are unable to answer. J 
Am Med Inform Assoc. 2007;14:407-14. 10.1197/jamia.M2398: 10.1197/jamia.M2398 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
 
Supplementary data 
 
Appendix Table 1: examples of single and multiple topic searches entered into the Trip search interface 
Example of single topic 
searches entered 
Examples of multiple topic searches entered 
tuberculosis xylitol otitis media 
manuka honey transfer patient to the floor 
tuberculosis pneumonia AND alcoholism 
Typhoid fever allergy to grass 
fungal nail infection Benzodiazepines cause respiratory depression with a shift of the 
CO2 response curve to the right 
vitamin c (Rotational coronary angiography) from:1990 to:2012 
aids (eating disorder OR anorexia) AND refeeding syndrome AND 
(control OR prevention OR monitoring) 
inhibin b Heart failure with preserved ejection fraction AND TREATMENT 
 
Appendix Table 2: Search terms used to identify ARI questions 
a) Disease search terms 
Disease Synonyms 
Acute Otitis Media Otitis media OR AOM OR Middle ear infection OR Middle ear infections OR 
Middle Ear Inflammation OR Middle Ear Inflammations OR Glue ear 
Bronchiolitis  Bronchiolitides OR Inflammed bronchioles OR Inflammation of the bronchioles 
Bronchitis  Bronchitides OR Inflamed bronchi OR Inflammation of the Bronchi OR 
Tracheobronchitis 
Common cold  Common colds OR Cold OR Colds OR Rhinovirus OR Rhinoviruses OR Coryza OR 
Catarrh OR Catarrhs 
Cough Coughs OR Coughing 
Croup Pseudocroup OR Laryngotracheobronchitis OR Stridor 
Infectious 
mononucleosis 
Glandular Fever 
Influenza Flu 
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Laryngitis Laryngitides 
Measles Chicken Pox 
Meningitis Meningitis OR Meningitides OR Meningitidis OR Meningeal  
Mumps  
Nasopharyngitis Nasopharyngitides 
Pertussis Whooping cough 
Pharyngitis Sore throats OR Sore throat OR Rhinopharyngitis OR Tonsillitis OR Tonsillitides 
Pneumococcus Pneumococcal 
Pneumonia Bronchopneumonia OR Pleuropneumonia OR Pleuropneumonia 
Respiratory 
syncytial virus 
RSV OR Respiratory Syncytial Viruses 
Respiratory tract 
infection  
Respiratory tract infections OR Respiratory infection OR Respiratory infections 
OR Respiratory inflammation OR Respiratory tract inflammation OR ARI OR URTI 
OR LRTI 
Rhinorrhea Rhinorrhoea 
Rubella  
SARS Severe Acute Respiratory Syndrome Virus OR Coronavirus 
Sinusitis Rhinosinusitis OR Sinus Infection OR Sinus Infections OR rhinitis OR nasosinusitis 
OR Nasosinusitis OR Runny nose 
Wheeze Wheezing 
 
b) Treatment search terms 
Intervention Synonyms 
Treatment Treat OR Treating 
Acupuncture  
Antibiotics Anti-Bacterial Agents OR Antibiotic OR antibacterial OR anti-bacterials OR 
Anti-microbial OR Antimicrobial OR Antimicrobials OR amoxicillin OR 
amoxycillin OR penicillin OR ampicillin OR cotrimoxazole OR chloramphenicol 
OR trimethoprim OR sulphamethoxazole OR tmp smx 
Anticholinergic  
Anticytokine  
Antihistamine  
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Antitussive Antitussives OR Cough Suppressants OR Decongestant OR expectorant OR 
oxymetazoline OR norepinephrine OR pseudoephedrine OR phenylephrine OR 
xylometazoline OR tramazoline OR Ephedrine OR ephedrin 
Antiviral Antivirals 
Bronchodilator  
CAM Complementary Therapies OR Complementary Therapy OR Complementary 
Medicine OR Alternative Medicine OR Alternative Medicines OR Alternative 
Therapies OR Alternative Therapy 
Continuous positive 
airway pressure 
CPAP OR AIrway pressure 
Corticosteroid Corticosteroid OR Corticosteroids OR steroid OR Steroids OR glucocorticoid OR 
hydrocortisone OR cortisone OR triamcinolone OR prednisone OR 
prednisolone OR methylprednisolone OR dexamethasone OR cortisol 
Counselling  
Deoxyribonuclease  
Education  
Exercise Running OR Walking OR Jogging OR  
Fluid therapy  
Glycerol  
Heliox Helium OR heliox OR heo2 OR he-o2 OR "he o2" 
Humidification Steam 
Immunoglobulin Immunoglobulins OR RSV-igiv OR Respigam OR Palivizumab OR Synagis 
Immunostimulant  
Immunotherapy  
Hand washing Handwashing OR Hand-washing OR Hand hygiene 
Masks Mask 
Infection control Quarantine OR Isolation OR Isolate 
Leukotriene  
Nasal irrigation Nasal wash OR Saline wash OR Saline irrigation 
NSAID NSAIDs OR Non-Steroidal Anti-Inflammatory Agents OR Non-Steroidal Anti-
Inflammatory Agent OR Ibuprofen  
Oxygen therapy  
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Paracetamol Acetaminophen OR paracetamol OR acetaminophen OR acetominophen OR 
tylenol 
Physiotherapy  
Positioning Posture OR Position OR Supine OR Prone OR Face down OR Lateral OR Upright 
OR Semirecumbent 
Probiotic Probiotics OR Lactobacillus OR Yoghurt OR Fermented milk OR Cultured Milk  
Procalcitonin Calcitonin 
Public health  
Radiography  
Statins  
Surfactant  
Surgery  
Topical analgesia Topical analgesic OR Topical analgesics OR Antipyrine OR Phenazone OR 
americaine otic OR aurafair OR auralgan OR auralgesic OR auraphene OR 
aurisan OR auroto OR dolotic OR lanaurine otocain OR omedia OR oticaine OR 
otigesic OR otocalm OR Rx-Otic OR sedaural OR tympagesic 
Vaccination Vaccine OR Vaccines 
Vitamin A  
Vitamin C  
Xylitol  
Zinc Galzin OR Zincteral OR Orazinc 
 
c) Diagnosis search terms 
Diagnosi
s 
Synonyms 
Diagnosi
s 
Diagnostic OR Diagnoses OR Rapid antigen OR Rapid test OR Rapid tests OR adt OR radts 
OR rdt OR rdts OR Antigen detection OR Physical examination OR Physical exam OR 
Detection Test OR Detection tests OR Reagent OR Kit OR Kits OR Assay OR Assays OR 
Reagent OR Reagents OR Dipstick OR Dipsticks OR Predictive value OR Scores OR Score OR 
CENTOR OR McIsaac OR Predict 
 
d) Prognosis search terms 
Prognosi Synonyms 
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s 
Prognosi
s 
Prognoses OR Prognostic OR Resolution OR Prediction OR Disease Progression OR Duration 
OR Progress OR Progression OR Self-limiting OR Self limiting OR Spontaneously remitting 
OR Spontaneously-remitting OR Resolve OR Resolves OR Resolution OR Severity of Illness  
Mortalit
y 
Survival OR Life expectancy OR Death 
 
Appendix Table 3 Top 20 ARI Clinical Questions with corresponding Cochrane Reviews (CR) 
Rank Topic No. of searches No. of Cochrane Reviews 
1 Influenza + Vaccination 4989 9 [21-29] 
2 Acute Otitis Media + Antibiotics 3578 4 [30-33] 
3 Common cold + Vitamin C 3528 1 [34] 
4 Meningitis + Corticosteroids 1910 4 [35-38] 
5 Pneumonia + Non-specific treatment 1765 0* [39-49] 
6 Pharyngitis + Antibiotics 1476 4 [50-53] 
7 Pneumonia + Antibiotics 1422 12 [43-47, 54-60] 
8 Pharyngitis + Corticosteroids 1324 2 [61, 62] 
9 Croup + Corticosteroids 1292 4 [63-66] 
10 Pneumococcus + Vaccination 1040 7 [67-73] 
11 Sinusitis + Treatment 1036 5 [74-78] 
12 Sinusitis + Antibiotics 1026 1 [78] 
13 Acute Otitis Media + Treatment 963 8 [30, 31, 33, 68, 79-82] 
14 Common cold + Zinc 832 1 [83] 
15 Bronchiolitis + Corticosteroids 786 2 [84, 85] 
16 Pharyngitis + Treatment 782 6 [50-52, 62, 86, 87] 
17 Pneumonia + Diagnosis 778 1 [88] 
18 Pneumonia + Corticosteroids 710 3 [40, 89, 90] 
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19 Sinusitis + Corticosteroids 674 1 [76] 
20 Bronchiolitis + Non-specific treatment 630 0* [84, 85, 91-103] 
* Cochrane protocols address this question and/or existing Cochrane reviews partially answer it. 
 
Appendix Table 4: List of topics with 100 or more searches 
Topic No. of searches %  of searches 
Influenza + Vaccination 4989 12.1 
Acute Otitis Media + Antibiotics 3578 8.7 
Common cold + Vitamin C 3528 8.6 
Meningitis + Corticosteroids 1910 4.6 
Pneumonia + Treatment 1765 4.3 
Pharyngitis + Antibiotics 1476 3.6 
Pneumonia + Antibiotics 1422 3.5 
Pharyngitis + Corticosteroids 1324 3.2 
Croup + Corticosteroids 1292 3.1 
Pneumococcus + Vaccination 1040 2.5 
Sinusitis + Treatment 1036 2.5 
Sinusitis + Antibiotics 1026 2.5 
Acute Otitis Media + Treatment 963 2.3 
Common cold + Zinc 832 2.0 
Bronchiolitis + Corticosteroids 786 1.9 
Pharyngitis + Treatment 782 1.9 
Pneumonia + Diagnosis 778 1.9 
Pneumonia + Corticosteroids 710 1.7 
Sinusitis + Corticosteroids 674 1.6 
Bronchiolitis + Treatment 630 1.5 
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Common cold + Treatment 576 1.4 
Pneumonia + Mortality 567 1.4 
Cough + Treatment 531 1.3 
Pertussis + Vaccination 502 1.2 
Meningitis + Treatment 477 1.2 
Croup + Treatment 428 1.0 
Bronchitis + Antibiotics 409 1.0 
Influenza + Treatment 384 0.9 
Measles + Vaccination 379 0.9 
Sinusitis + Diagnosis 344 0.8 
Meningitis + Antibiotics 313 0.8 
Respiratory tract infection + Antibiotics 298 0.7 
Pharyngitis + Diagnosis 293 0.7 
Pneumonia + Vaccination 282 0.7 
Influenza + Mortality 277 0.7 
Pneumonia + Prognosis 268 0.7 
Wheeze + Corticosteroids 247 0.6 
Influenza + Diagnosis 221 0.5 
Meningitis + Mortality 202 0.5 
Rubella + Vaccination 192 0.5 
Common cold + Antibiotics 186 0.5 
Sinusitis + Immunotherapy 180 0.4 
Bronchitis + Treatment 177 0.4 
Pneumonia + Procalcitonins 177 0.4 
Pneumonia + Physiotherapy 176 0.4 
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Bronchiolitis + CPAP 167 0.4 
Respiratory tract infection + Treatment 161 0.4 
Meningitis + Diagnosis 157 0.4 
Pertussis + Treatment 154 0.4 
Acute Otitis Media + Corticosteroids 149 0.4 
Acute Otitis Media + Prognosis 146 0.4 
Acute Otitis Media + Diagnosis 137 0.3 
Pneumonia + Probiotics 133 0.3 
Sinusitis + Acupuncture 132 0.3 
Cough + Antibiotics 129 0.3 
Influenza + Antiviral 127 0.3 
Mumps + Vaccination 126 0.3 
Cough + Corticosteroids 115 0.3 
Sinusitis + Antihistamine 114 0.3 
Cough + Vaccination 110 0.3 
Meningitis + Vaccination 110 0.3 
Bronchiolitis + Physiotherapy 109 0.3 
Pneumonia + Radiography 109 0.3 
Bronchiolitis + Antibiotics 103 0.3 
Influenza + Vitamin C 103 0.3 
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Pneumonia 778 268 567 5,207 1,765 1,422 2 282 3 710 133 82 4 55 2 52 8 16 3 ## 3 2 6 59 109 177 16 11 65 6 9 # 6 4 1 6,820
Influenza 221 59 277 5,938 384 54 2 4,989 32 22 8 28 2 3 2 5 10 34 127 3 103 96 11 # 3 2 6,495
Common cold 9 56 5 5,469 576 186 39 11 53 22 7 60 832 7 18 24 24 7 15 1 12 16 24 3,528 1 6 5,539
Acute Otitis Media 137 146 9 4,862 963 26 3,578 2 19 46 18 149 4 14 6 6 7 10 8 5 1 5,154
Pharyngitis 293 64 4 3,702 782 1,476 4 34 1,324 4 36 20 2 1 3 4 7 1 2 1 1 4,063
Sinusitis 344 78 3 3,451 1,036 1,026 180 41 3 4 674 92 23 1 3 1 114 56 132 7 1 7 22 15 6 6 1 3,876
Meningitis 157 32 202 2,852 477 313 110 1,910 7 1 3 2 12 6 3 3 1 4 3,243
Bronchiolitis 52 30 14 2,062 630 103 9 786 1 5 1 167 53 1 ## 36 4 92 46 5 3 4 5 2 2,158
Croup 31 4 1,755 428 6 1,292 1 13 15 1,790
Pneumococcus 8 2 30 1,106 16 33 1,040 10 1 6 1,146
Cough 77 24 5 1,033 531 129 63 110 115 1 2 4 9 10 8 2 5 2 4 7 5 4 19 2 1 1,139
Respiratory tract infection 38 37 15 817 161 298 2 18 1 5 28 23 79 25 1 15 2 2 3 1 1 2 1 3 48 23 4 43 8 11 8 1 907
Pertussis 57 7 20 702 154 28 502 16 1 1 786
Bronchitis 25 19 3 706 177 409 5 3 63 1 1 1 3 9 8 1 1 2 2 20 753
Measles 14 9 533 48 29 379 10 7 5 2 7 5 8 3 # 556
Wheeze 9 5 278 19 1 247 1 2 5 3 292
Rubella 6 1 1 230 29 192 2 6 1 238
Respiratory syncytial virus 16 1 3 168 37 13 29 3 4 4 1 74 3 188
Mumps 1 5 148 17 126 2 1 2 154
Infectious mononucleosis 22 1 68 26 6 2 1 28 3 2 91
Laryngitis 1 81 36 7 36 2 82
SARS 3 13 4 9 16
Rhinorrhea 9 2 1 2 2 2 9
Nasopharyngitis 1 1 1
Totals #### 834 #### ##### 8,298 26 9,105 184 200 7,822 161 7,467 ## 318 992 28 80 177 195 156 84 179 77 9 ## 49 8 106 148 17 125 133 242 98 167 88 #### ## 40 # 6 8 # 4 1 4 #####
